CXCL5 is highly expressed in hepatocellular and prostate cancers (10, 11), as well as cholangiocarcinoma (12) and esophageal squamous carcinoma (13), promoting tumor growth and metastasis as a key protein involved in the regulatory of cancer immunity enriched in the migrasome. This evidence concerns the gene CXCL5 and neoplasm.